Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Extracellular Nanoparticles Sourced From Another Species Reverses Biological Age of Rats by More Than 50% 2023-11-01 09:14
Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata 2023-11-01 09:05
Antengene Presents Results from Five Investigational Programs at 2023 SITC Annual Meeting 2023-11-01 08:30
Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S. 2023-10-31 21:44
88th CMEF Unveils Cutting-Edge Medical Breakthroughs in Shenzhen, Unleashing the Latest Medical Technologies and Solutions 2023-10-31 21:34
Lunit Joins as an Associate Partner with the World Economic Forum 2023-10-31 21:00
BioLineRx Entered Exclusive License Agreement to Motixafortide in Asia, Advised by MSQ Ventures 2023-10-31 21:00
YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine 2023-10-31 20:30
Meihua International Medical Technologies Co., Ltd. Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device Technologies to China and Hainan Free Trade Port Boao Hope City 2023-10-31 20:00
HOYA Vision Care Releases One-Year MiYOSMART European Study Results 2023-10-31 19:13
CHIMERIC THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR CHM 2101, A NOVEL CDH17 CAR T CELL THERAPY FOR ADVANCED GASTROINTESTINAL CANCERS 2023-10-31 19:00
Select the Right Medical-Grade TPU:ICP DAS - BMP Launches a New TPU Series at COMPAMED & IPF Japan 2023 2023-10-31 16:38
Biotechnology Start-Up Psylo Wins Hello Tomorrow APAC Deep Tech Competition in Singapore 2023-10-31 15:42
iNtRON, Executes Evaluation License and Option Agreement for SAL200 2023-10-31 12:20
CStone Announces NMPA Approval of Sugemalimab for Patients with Relapsed or Refractory Extranodal NK/T-cell Lymphoma, the First Anti-PD-1/PD-L1 mAb Approved for this Indication 2023-10-31 10:16
AffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery 2023-10-31 09:35
SK Life Science Labs, a Subsidiary of SK Biopharmaceuticals, Presents Discovery of Oral SMARCA2 Degraders Data at 6th Annual Targeted Protein Degradation Summit 2023-10-31 08:00
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC 2023-10-31 07:00
LifeSpan Vision Ventures Invests in NaNotics 2023-10-31 02:26
Pulsecare Medical's nsPFA clinical trial receives satisfactory short-term follow-up results 2023-10-30 23:02
1 59 60 61 62 63 892